Shanghai Yizhong Pharmaceutical Co., Ltd. (688091)

Market Closed

7 Aug, 06:57

SSE

40. 86

+1.93

+4.9576%

7.19B Market Cap

- P/E Ratio

1.24% Div Yield

4.32M Volume

- Eps

¥ 38.93

Previous Close

Add Transaction

Day Range

38.56 40.94

Year Range

35.28 83.6

Want to track 688091 and more in your Portfolio? 🎯

Get Started For Free

Summary

688091 closed Friday higher at ¥40.86, an increase of 4.9576% from Thursday's close, completing a monthly increase of 2.15% or ¥0.86. Over the past 12 months, 688091 stock lost -12.3176%.

688091 is not paying dividends to its shareholders.

The last earnings report, released on Apr 29, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.

Shanghai Yizhong Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 17, 2024.

The company's stock is traded on one exchange.

688091 Chart

People also search for

688131

Shanghai Haoyuan Chemexpress Co., Ltd.

¥ 95

-2.7934%

688276

Changchun BCHT Biotechnology Co., Ltd.

¥ 15.91

-0.5003%

603055

Zhejiang Taihua New Material Co., Ltd.

¥ 8.45

+0.1185%

603219

Ningbo Fujia Industrial Co., Ltd.

¥ 14.49

+0.9053%

600686

Xiamen King Long Motor Group Co., Ltd.

¥ 12.16

+0.33%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091) FAQ

What is the stock price today?

The current price is ¥40.86.

On which exchange is it traded?

Shanghai Yizhong Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688091.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.24%.

What is its market cap?

As of today, the market cap is 7.19B.

Has Shanghai Yizhong Pharmaceutical Co., Ltd. ever had a stock split?

Shanghai Yizhong Pharmaceutical Co., Ltd. had 3 splits and the recent split was on May 17, 2024.

Shanghai Yizhong Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry	Consumer Discretionary Sector	Mr. Jingsong Zhou CEO	SSE Exchange	CNE1000050F4 ISIN
CN Country	304 Employees	17 May 2024 Last Dividend	17 May 2024 Last Split	- IPO Date

Overview

Shanghai Yizhong Pharmaceutical Co., Ltd., established in 2009, stands as a proactive entity in the Chinese pharmaceutical landscape, specializing in the realm of oncology. With its headquarters nestled in Shanghai, China, the company asserts a commendable focus on the development, production, and distribution of anti-tumor drugs and associated healthcare solutions within the region. Through its dedication to innovation and excellence in the pharmaceutical industry, Shanghai Yizhong Pharmaceutical Co., Ltd. endeavors to contribute significantly to the global fight against cancer, positioning itself as a pivotal player in the healthcare sector.

Products and Services

Paclitaxel Polymer Micelle:
This flagship product by Shanghai Yizhong Pharmaceutical Co., Ltd. represents a groundbreaking advancement in the treatment of small cell lung cancer. Utilizing innovative polymer micelle technology, this formulation of Paclitaxel enhances the delivery and efficacy of the drug, offering a potent therapeutic option for patients battling this formidable type of cancer. By focusing on such a specialized treatment solution, Shanghai Yizhong underscores its commitment to addressing the intricate challenges faced in oncology.

Contact Information

Address: No.79 Renqi Road, Shanghai, China, 201403

Phone: 86 21 3719 0005

Website: https://www.yizhongpharma.com

Blog Affiliate Program About Terms Privacy Help Contact Us